advertising
-
1.
Atway S , Nerone VS & Springer KD et al.: Rate of residual osteomyelitis after partial foot amputation in diabetic patients: a standardized method for evaluating bone margins with intraoperative culture. J Foot Ankle Surg 51 : 749, 2012.
-
2.
Cierny G III: Surgical treatment of osteomyelitis. Plast Reconstr Surg 127 (suppl 1) : 190S, 2011.
-
3.
Izumi Y , Satterfield K & Lee S et al.: Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care 29 : 566, 2006.
-
4.
Miclau T , Dahners LE & Lindsey RW: In-vitro pharmockinetics of antibiotic release from locally implantable materials. J Orthop Res 11 : 627, 1993.
-
5.
Walenkamp GHIM: How I do it: chronic osteomyelitis. Acta Orthop Scand 68 : 497, 1997.
-
6.
Reffitt DM , Ogston N & Jugdaohsingh R et al.: Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32 : 127, 2003.
-
7.
Keeting PE , Oursler MJ & Wiegand KE et al.: Zeolite A increases proliferation, differentiation, and transforming growth factor β production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 7 : 1281, 1992.
-
8.
Soares P , Laurindo CAH & Torres RD et al.: Effect of a bioactive glass-ceramic on the apatite nucleation on titanium surface modified by micro-arc oxidation. Surf Coat Technol 206 : 4601, 2012.
-
9.
Damen JJM & Ten Cate JM: Silica-induced precipitation of calcium phosphate in the presence of inhibitors of hydroxyapatite formation. J Dent Res 71 : 453, 1992.
-
10.
Kokubo T & Takadama H: How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27 : 2907, 2006.
-
11.
Grinnell F & Feld MK: Adsorption characteristics of plasma fibronectin in relationship to biological activity. J Biomed Mater Res 15 : 363, 1981.
-
12.
Ducheyne P & Qiu Q: Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 20 : 2287, 1999.
-
13.
Porter AE: Nanoscale characterization of the interface between bone and hydroxyapatite implants and the effect of silicon on bone apposition. Micron 37 : 681, 2006.
-
14.
Zreiqat H , Howlett CR & Zannettino A et al.: Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 62 : 175, 2002.
-
15.
Grime PD , Bowerman JE & Weller PJ: Gentamicin impregnated polymethylmethacrylate (PMMA) beads in the treatment of primary chronic osteomyelitis of the mandible. Br J Oral Maxillofac Surg 28 : 367, 1990.
-
16.
Murray WR: Use of antibiotic-containing bone cement. Clin Orthop Rel Res 190 : 89, 1984.
-
17.
Josefsson G , Gudmundsson G & Kolmert L et al.: Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A 5-year survey of 1688 hips. Clin Orthop Rel Res 253 : 173, 1990.
-
18.
Jenny G: Local antibiotic therapy using gentamicin-PMMA chains in post-traumatic bone infections. Short and long-term results. Reconstr Surg Traumatol 20 : 36, 1988.
-
19.
Calhoun JH & Mader JT: Antibiotic beads in the management of surgical infections. Am J Surg 157 : 443, 1989.
-
20.
Korkusuz F , Uchida A & Shinto Y et al.: Experimental implant-related osteomyelitis treated by antibiotic-calium hydroxyapatite ceramic composites. J Bone Joint Surg Br 75 : 111, 1993.
-
21.
Shinto Y , Uchida A & Korkusuz F et al.: Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 74 : 600, 1992.
-
22.
Jogia RM , Modha DE & Nisal K et al.: Use of highly purified synthetic calcium sulfate impregnated with antibiotics for the management of diabetic foot ulcers complicated by osteomyelitis. Diabetes Care 38 : e79, 2015.
-
23.
Karr JC: Management in the wound-care center outpatient setting of a diabetic patient with forefoot osteomyelitis using Cerament Bone Void Filler impregnated with vancomycin: off-label use. JAPMA 101 : 259, 2011.
-
24.
Koort JK , Mäkinen TJ & Suokas E et al.: Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 49 : 1502, 2005.
-
25.
Garvin KL , Miyano JA & Robinson D et al.: Polylatide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J Bone Joint Surg Am 76 : 1500, 1994.
-
26.
Stemberger A , Grimm AH & Bader F et al.: Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg 163 : 17, 1997.
-
27.
Wachol-Drewek Z , Pfeiffer M & Scholl E: Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 17 : 1733, 1996.
-
28.
Lin BR , Caldwell C & Bhaduri S et al.: Optimizing vancomycin release from calcium phosphate-based cement by carboxymethyl cellulose for prevention of osteomyelitis. Surg Infect 18 : 221, 2017.
Improving Outcomes for Osteomyelitis After Partial Bone Resection: A Preliminary Report
Search for other papers by Jeffrey C. Karr in
Current site
Google Scholar
PubMed
Following partial bone resection for osteomyelitis, continued osteomyelitis in the remaining bone is common and problematic. Shortcomings in available surgical techniques to combat this also contribute to this problem. Presented are two case studies using a solution to this problem with a different type of bone void filler as a carrier vehicle for delivering antibiotics into the remaining infected bone to eradicate any residual bacteria in the remaining bone.
The Osteomyelitis Center of Central Florida, 5421 S Florida Ave, Lakeland, FL 33813. (E-mail: drkarr@gmail.com)
advertising
